2007
DOI: 10.1007/s00415-006-0405-7
|View full text |Cite
|
Sign up to set email alerts
|

Cranial and peripheral neuropathy due to leptomeningeal infiltration in a patient with Waldenstrom's macroglobulinemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 6 publications
0
4
0
Order By: Relevance
“…A demyelinating pattern was seen in the remainder, of which two‐thirds had anti‐myelin‐associated glycoprotein (anti‐MAG) antibodies, and one‐third had chronic inflammatory demyelinating polyradiculopathy . The 2 patients with neurolymphomatosis in Viala's series and the 6 previously reported cases had clinical presentations different from our patient; they had enhancing cauda equina masses on magnetic resonance imaging and CSF lymphocytosis. Our patient, by contrast, had typical clinical features of CANOMAD.…”
Section: Discussionmentioning
confidence: 48%
“…A demyelinating pattern was seen in the remainder, of which two‐thirds had anti‐myelin‐associated glycoprotein (anti‐MAG) antibodies, and one‐third had chronic inflammatory demyelinating polyradiculopathy . The 2 patients with neurolymphomatosis in Viala's series and the 6 previously reported cases had clinical presentations different from our patient; they had enhancing cauda equina masses on magnetic resonance imaging and CSF lymphocytosis. Our patient, by contrast, had typical clinical features of CANOMAD.…”
Section: Discussionmentioning
confidence: 48%
“…Case reports of patients developing cranial neuropathies during treatment or many years into the illness have been described, probably due to different pathogenic mechanisms involved. Sutter et al, have documented a case of WM with double vision, and bulbar palsy, and attributed it to the progression of disease due to meningeal infiltration [ 7 ]. Klokkevold et al, have reported a 43 years old lady with 7 years of WM on treatment with mental nerve involvement [ 8 ].…”
Section: Discussionmentioning
confidence: 99%
“…Both questions do speak to problems with calculation, but the PASAT performance measure is actually testing attention and concentration functions. In addition, there is some question about how accurate self-report can be regarding cognitive change [18]– can a person with MS accurately gauge his or her own cognitive changes, when s/he is having cognitive changes? However, even if individuals experiencing changes in cognitive function cannot accurately report or quantify the changes, self-reports offer a complement to performance tests as a measure of how aware a person with MS is of the cognitive changes that are taking place, and if cognitive ability to sense one’s own condition is being affected by the MS.…”
Section: Discussionmentioning
confidence: 99%